Integrating Botanical Drugs into Western Medicine
Integrating Botanical Drugs into Western Medicine https://abvcpharma.com/wp-content/themes/movedo/images/empty/thumbnail.jpg 150 150 ABVC https://secure.gravatar.com/avatar/a3e365cc0b2e9c8ef9f2c3b6608e59427a68cb9f975a8c9d2135842af27caf85?s=96&d=mm&r=ghttps://www.youtube.com/watch?v=TYrNEA0mG-8 In this episode of Biotech Orbit, host Victor Lee speaks with our CEO, Dr. Utam Patil. Here he discusses our botanical-based therapies for major depressive disorder (MDD) and cancer. The conversation explores the unique advantages and regulatory challenges of botanical drugs, which are derived from natural plant and fungal sources. Dr. Patil shares that ABVC’s lead candidate for MDD, ABV-1504, is entering a Phase 3 clinical trial and has shown no signs of suicidal ideation or addiction which is a common concerns with synthetic antidepressants. This positions ABV-1504 as a promising alternative, particularly since it functions as a single…

